Dapagliflozin Patient Satisfaction Survey

Inclusion Criteria

• • At least one pharmacy claim for dapagliflozin or dapagliflozin/metformin ER in the most recent month of pharmacy data and no pharmacy claims for an SGLT2 medication during the 6 months prior to sample identification.
• • Evidence of T2D diagnosis.
• • Age ≥18 as of the drug index date.
• • 6 months of continuous enrollment in a commercial health plan with both pharmacy and medical benefits during the identification period through the patient interview sample identification date.
• • Self-reported T2D diagnosis during the patient interview.